Browsing: filaggrin

Azitra, a biopharmaceutical company, is developing a clinically backed anti-aging ingredient with potential applications for post GLP-1 skin laxity. The ingredient, ATR-COSF, utilizes a novel supernatant formulation that contains an active recombinant human domain of the protein filaggrin (rHDfilaggrin) for cosmetic and skin care applications